Cellex develops devices for the pharmaceutical industry and, with the support of Bluegreen, has secured funding through the SME Instrument, Medio Credito Centrale, and was awarded a €360K grant under the Smart&Start program.
Cellex is an innovative startup founded in June 2018, with a core business focused on the development of bioreactors for advanced cell culture and tissue engineering.
About the project
Cellex is currently focused on the design, development, and production of SUSPENCE, a highly innovative and scalable bioreactor that keeps cells in suspension within a culture chamber, allowing them to grow and mature under dynamic conditions.